Published On: Wed, Apr 29th, 2015

Mylan raises offer to buy Perrigo to $35.6 billion

(L-R) Robert J Coury,   Mylan ,   Joseph Papa,   Periggo

Mylan, itself the subject of a hostile takeover bid from Teva, is raising its offer for Perrigo for the second time.

Mylan N.V. has for the second time raised its offer to buy US-Irish-Israeli generic pharmaceuticals company Perrigo Company (NYSE:PRGO; TASE:PRGO). Mylan is now offering Perrigo shareholders $75 plus 2.3 Mylan shares per Perrigo share for a total of about $35.6 billion.

The new offer reflects a share price of about $232.23 per Perrigo share based on prices on April 8 when Mylan made its first offer. The previous offer, which was rejected by Mylan, was for $222 per Perrigo share, comprising $60 in cash and 2.2 Mylan shares…


Published by Globes [online], Israel business news –

Read more about: , , , , , , , , , ,

Wordpress site Developed by Fixing WordPress Problems